@Article{info:doi/10.2196/21878,
author="Abid, Leila
and Hammami, Rania
and Abdesselem, Salem
and Boudiche, Selim
and H{\'e}di, Ben Slima
and Sayahi, Khaled
and Bahloul, Amine
and Chamtouri, Ikram
and Charfeddine, Salma
and Rais, Lamia
and Drissa, Meriem
and Ben Kaab, Badreddine
and Ibn hadj amor, Hassen
and Ben Fatma, Lilia
and Garbaa, Riadh
and Boukhris, Sabrine
and Emna, Allouche
and Ben Halima, Manel
and Amdouni, Nesrine
and Ghorbel, Shayma
and Soudani, Sabrine
and Khaled, Imen
and Triki, Syrine
and Bouazizi, Feten
and Jemai, Imen
and Abdeljalil, Ouday
and Ammar, Yemna
and Farah, Amani
and Neji, Adnen
and Oumaya, Zeineb
and Seghaier, Sana
and Mokrani, Samir
and Thawaba, Hamza
and Sarray, Hela
and Ouaghlani, Khalil
and Thabet, Houssem
and Mnif, Zeineb
and Fatma, Boujelben Masmoudi
and Sghaier, Mohamed
and Khalifa, Roueida
and Fourati, Sami
and Kammoun, Yassmine
and Abid, Syrine
and Hamza, Chiheb
and Ben Jeddou, Syrine
and Sabbah, Lassaad
and Lakhdhar, Rim
and Dammak, Najla
and Sellami, Tarak
and Herbegue, Basma
and Koubaa, Alia
and Triki, Faten
and Ellouze, Tarek
and Hmoudi, Aicha
and Ben Ameur, Ikhlas
and Boukhchina, Mohamed Mongi
and Abid, Neila
and Ouechtati, Wejdene
and Nasrallah, Nizar
and Houidi, Yousra
and Mghaieth Zghal, Fathia
and Elhem, Ghodhbane
and Chayeb, Mounira
and Sarra, Chenik
and Kaabachi, Samira
and Saadaoui, Nizar
and Ben Ameur, Ines
and Affes, Moufida
and Ouali, Sana
and Chaker, Mouna
and Naana, Hela
and Meriem, Dghim
and Jarrar, Mourad
and Mnif, Jihen
and Turki, Ahmed
and Zairi, Ihsen
and Langar, Jamel
and Dardouri, Safa
and Hachaichi, Imen
and Chettaoui, Rafik
and Smat, Wajih
and Chakroun, Amel
and Mzoughi, Khadija
and Mechmeche, Rachid
and Ben Halima, Afef
and Ben Kahla Koubaa, Sahar
and Chtourou, Slim
and Mohamed abdelkader, Maalej
and Ayari, Mohsen
and Hadrich, Moufid
and Rami, Tlili
and Azaiez, Fares
and Bouhlel, Imen
and Sahnoun, Samir
and Jerbi, Habib
and Imtinene, Ben Mrad
and Riahi, Leila
and Sahnoun, Mohamed
and Ben Jemaa, Abdelhamid
and Ben Salem, Amal
and Rekik, Bassem
and Ben Doudou, Maroua
and Boujnah, Mohamed Rachid
and Joulak, Anissa
and Omar, Abid
and Razgallah, Rabie
and Sami, Milouchi
and Neffati, Elyes
and Gamra, Habib
and Ben Youssef, Soraya
and Sdiri, Wissem
and Ben Halima, Nejeh
and Ben Ameur, Youssef
and Kachboura, Salem
and Kraiem, Sondes
and Fehri, Wafa
and Zakhama, Lilia
and Bezdah, leila
and Mohamed Sami, Mourali
and Drissa, Habiba
and Maatouk, Mohamed Faouzi
and Kammoun, Samir
and Addad, Faouzi",
title="Design and Rationale of the National Observational Multicentric Tunisian Registry of Hypertension: Protocol for Evaluating Hypertensive Patient Care in Clinical Practice",
journal="JMIR Res Protoc",
year="2022",
month="Sep",
day="2",
volume="11",
number="9",
pages="e21878",
keywords="National Tunisian Registry; hypertension",
abstract="Background: This study was designed to evaluate the care of hypertensive patients in daily clinical practice in public and private centers in all Tunisian regions. Objective: This study will provide us an overview of hypertension (HTN) management in Tunisia and the degree of adherence of practitioners to international recommendations. Methods: This is a national observational cross-sectional multicenter study that will include patients older than 18 years with HTN for a duration of 4 weeks, managed in the public sector from primary and secondary care centers as well as patients managed in the private sector. Every participating patient signed a consent form. The study will exclude patients undergoing dialysis. The parameters that will be evaluated are demographic and anthropometric data, lifestyle habits, blood pressure levels, lipid profiles, treatment, and adherence to treatment. The data are collected via the web interface in the Dacima Clinical Suite. Results: The study began on April 15, 2019 and ended on May 15, 2019. During this period, we included 25,890 patients with HTN. Data collection involved 321 investigators from 24 Tunisian districts. The investigators were doctors working in the private and public sectors. Conclusions: Observational studies are extremely useful in improving the management of HTN in developing countries. Trial Registration: ClinicalTrials.gov NCT04013503; https://clinicaltrials.gov/ct2/show/NCT04013503 International Registered Report Identifier (IRRID): DERR1-10.2196/21878 ",
issn="1929-0748",
doi="10.2196/21878",
url="https://www.researchprotocols.org/2022/9/e21878",
url="https://doi.org/10.2196/21878",
url="http://www.ncbi.nlm.nih.gov/pubmed/36053572"
}